Education
About Us
Working with TipRanks
Follow Us
Invion (AU:IVX)
ASX:IVX
IVX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.08 - AU$0.43
Previous CloseN/A
Volume36.17K
Average Volume (3M)114.31K
Market Cap
$9.34M
Enterprise ValueAU$8.18M
Total Cash (Recent Filing)$736.45K
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.42
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.10
Shares Outstanding84,875,800
10 Day Avg. Volume60,618
30 Day Avg. Volume114,312
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.54
Price to Sales (P/S)0.00
P/FCF Ratio-3.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Invion News
PremiumCompany Announcements
Invion Limited Securities Reinstated to ASX Quotation
PremiumCompany Announcements
Invion Limited Announces Quotation of New Securities
PremiumCompany Announcements
Invion Limited Releases Holdings Analysis
PremiumCompany Announcements
Invion Raises $1 Million Through Successful Entitlement Offer
PremiumCompany Announcements
Invion Limited’s IVXO Securities Suspended from Quotation
PremiumCompany Announcements
Invion Opens Entitlement Offer to Boost R&D Initiatives
PremiumCompany Announcements
Invion Director Alters Securities HoldingsPremiumCompany Announcements
Invion Director Increases Stake Through Option ExerciseOptions Prices
Currently, No data available
---
Ownership Overview
7.19% Insiders
―
Mutual Funds
― Other Institutional Investors
92.81% Public Companies and
Individual Investors
IVX FAQ
What was Invion’s price range in the past 12 months?
Invion lowest share price was AU$0.08 and its highest was AU$0.43 in the past 12 months.
What is Invion’s market cap?
Invion’s market cap is $9.34M.
When is Invion’s upcoming earnings report date?
Invion’s upcoming earnings report date is Aug 29, 2025 which is in 37 days.
How were Invion’s earnings last quarter?
Currently, no data Available
Is Invion overvalued?
According to Wall Street analysts Invion’s price is currently Overvalued.
Does Invion pay dividends?
Invion does not currently pay dividends.
What is Invion’s EPS estimate?
Invion’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Invion have?
Invion has 84,875,800 shares outstanding.
What happened to Invion’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Invion?
Currently, no hedge funds are holding shares in AU:IVX
Invion Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:IVX Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-90.27%
12-Months-Change
Fundamentals
Return on Equity
-44.03%
Trailing 12-Months
Asset Growth
-31.52%
Trailing 12-Months
Company Description
Invion
Invion (IVX) is a biotechnology company focused on the research, development, and commercialization of Photodynamic Therapy (PDT) for the treatment of various cancers. Operating primarily in the healthcare and pharmaceutical sectors, Invion is dedicated to advancing its novel technologies to offer innovative treatment solutions that can improve patient outcomes. The company's core products include its proprietary PDT compounds and related systems that leverage light-activated processes to target and destroy cancer cells.